Works matching IS 15391604 AND DT 2022 AND VI 21 AND IP 4

Results: 14

Foreword.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 701, doi. 10.1002/pst.2243
Publication type:: Article

A note from the editors.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 700, doi. 10.1002/pst.2242

By:

Senn, Stephen;
Smith, Mike K.

Publication type:

Article

Do statisticians count? A prior and posterior viewpoint.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 706, doi. 10.1002/pst.2229

By:

Jones, Margaret;
Hodgson, Gemma

Publication type:

Article

Rationale for the update algorithm of the graphical approach to sequentially rejective multiple test procedures.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 757, doi. 10.1002/pst.2227

By:

Maurer, Willi;
Bretz, Frank;
Posch, Martin

Publication type:

Article

The design and analysis of vaccine trials for COVID‐19 for the purpose of estimating efficacy.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 790, doi. 10.1002/pst.2226
Publication type:: Article

Viewpoint: Do not resurrect the two‐stage procedure.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 808, doi. 10.1002/pst.2224
Publication type:: Article

Simulation‐based sequential design.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 729, doi. 10.1002/pst.2216

By:

Müller, Peter;
Duan, Yunshan;
Garcia Tec, Mauricio

Publication type:

Article

From innovative thinking to pharmaceutical industry implementation: Some success stories.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 712, doi. 10.1002/pst.2222

By:

Walley, Rosalind;
Brayshaw, Nigel

Publication type:

Article

Reflecting on Andy Grieve's influence and innovation: A personal perspective.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 702, doi. 10.1002/pst.2220
Publication type:: Article

Informed decision‐making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 740, doi. 10.1002/pst.2219

By:

Weir, Christopher J.;
Taylor, Rod S.

Publication type:

Article

The Acute Stroke Therapy by Inhibition of Neutrophils study – Key features and impact.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 720, doi. 10.1002/pst.2218

By:

Kirby, Simon;
Chuang‐Stein, Christy

Publication type:

Article

Study‐design in pandemics: From surveillance and performance‐evaluation to licensing and pharmacovigilance.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 764, doi. 10.1002/pst.2217
Publication type:: Article

The cross‐over of statistical thinking and practices: A pandemic catalyst.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 778, doi. 10.1002/pst.2221
Publication type:: Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 4, p. 697, doi. 10.1002/pst.2136
Publication type:: Article